MariMed Exhibiting at Boston NECANN Conference to Introduce Branded Cannabis Products in Massachusetts

NEWTON, Mass., March 23, 2018 -- MariMed Inc. (OTCQB:MRMD), a Massachusetts-based, publically traded national cannabis company, is exhibiting at the New England Cannabis Convention (NECANN) convention, booth 927, at the Hynes Convention Center in Boston, March 24^th and 25^th.  MariMed will be introducing its precision-dosed, licensed branded products to the wide spectrum of attendees interested in the emerging Massachusetts cannabis marketplace.  MariMed will also offer a sneak peak of its soon-to-be-introduced Nature’s Heritage Cannabis^® line of branded products featuring the finest strains of cannabis Mother Earth has to offer. The Company expects to begin distribution of its products to medical cannabis dispensaries in the second quarter of 2018 and the adult use cannabis market after July 2018.

MariMed will introduce its branded precision dosed cannabis products to Massachusetts dispensaries at NECANN Booth 927.

MariMed’s branded product lines, which incorporate the purest cannabis strains grown using its eco-friendly sustainable cultivation techniques, include:

• Kalm Fusion^® cannabis infused, precision dosed powdered tincture drink mix, Kalm Corn popcorn, Oral thin strips and chewable tablets -- all in CBD and THC formulations;
• Betty’s Eddies™ precision dosed all natural fruit chews
• Tikun Olam™ licensed cannabis strains from Israel, where years of research and clinical trials were conducted with strains to effectively treat specific medical symptoms related to Crohn’s disease, chronic pain, inflammation, cerebral palsy, autism and more.
• LucidMood unique vape pens
• iRollie accessories

MariMed is currently completing the construction of cultivation, production, and multiple dispensary facilities for ARL Healthcare, its Massachusetts licensed cannabis client. MariMed has licensed its branded products in multiple legal states including at cannabis facilities developed and managed by the MariMed team in Delaware, Illinois, Nevada, Maryland, and Rhode Island.

Search MariMed and post on social media with the hash tag #MedicatedByMarimed:

Twitter: @MariMedInc    
Facebook: @MariMedInc
Instagram: MariMedInc
YouTube: MariMedInc

About MariMed Inc.:
MariMed is an industry leader in the development and operation of state licensed regulatory compliant cannabis cultivation, production, and dispensary facilities in multiple states nationwide.  These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations.  MariMed is also on the forefront of precision dosed branded products for the treatment of specific medical symptoms.  MariMed distributes its branded products in select states and is currently expanding licensing and distribution to numerous additional states encompassing thousands of dispensaries. 

MariMed Inc. is one of the 17 top-performing public cannabis companies in the U.S. tracked on the U.S. Marijuana Index, (www.marijuanaindex.com). For additional information, visit www.MariMedAdvisors.com

MariMed Contacts:
Business Development
Jon Levine, CFO, MariMed, Inc.
+1 844-244-0200

Investor Relations
Tyler Troup, Circadian Group
[email protected]
+1 (866) 950 8300

Media Relations
Julie Shepherd, Accentuate PR
[email protected]
+1 847-275-3643

Forward Looking Statements:
This release contains certain forward-looking statements and information relating to MariMed Inc., that is based on the beliefs of MariMed Inc. management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the economic environment and changes in the legal status of cannabis. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned," "estimated," "preparing," “seek,” "potential," "expected" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites of any other party referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/62ddce3b-26b8-40be-9d0a-32a1fdf67e05